DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France. Its product pipeline comprising Viaskin Peanut, an immunotherapy product, which has...
Q2 2026
Jul 29, 2026
Q1 2026
Apr 30, 2026
FY 2025
Mar 26, 2026
Q4 2025
Q3 2025
Oct 28, 2025